athenahealth Stock Price, News & Analysis (NASDAQ:ATHN)

$128.33 2.80 (2.23 %)
(As of 01/22/2018 11:09 AM ET)
Previous Close$125.53
Today's Range$125.05 - $128.42
52-Week Range$95.01 - $158.66
Volume427,500 shs
Average Volume421,038 shs
Market Capitalization$5.14 billion
P/E Ratio166.66
Dividend YieldN/A
Beta1.58

About athenahealth (NASDAQ:ATHN)

athenahealth logoathenahealth, Inc. provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet. The Company has a range of network-enabled services to support healthcare providers across the continuum of care. The Company offers various combinations of its services to its clients, including athenaOne and athenaOne for Hospitals and Health Systems, depending on whether they are medical groups and practices or hospitals and larger health systems. As of December 31, 2016, the Company connected care across a national network of approximately 88,000 providers and approximately 86 million patients. Its suite of network-enabled services includes athenaCollector, athenaClinicals, athenaCommunicator, athenaCoordinator, Population Health and Epocrates.

Receive ATHN News and Ratings via Email

Sign-up to receive the latest news and ratings for ATHN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Software & Technology Services
Sub-IndustryHealth Care Technology
SectorMedical
SymbolNASDAQ:ATHN
CUSIP04685W10
Phone617-402-1000

Debt

Debt-to-Equity Ratio0.35%
Current Ratio1.67%
Quick Ratio1.67%

Price-To-Earnings

Trailing P/E Ratio166.662337662338
Forward P/E Ratio105.19
P/E Growth3

Sales & Book Value

Annual Sales$1.08 billion
Price / Sales4.74
Cash Flow$4.66 per share
Price / Cash27.51
Book Value$16.05 per share
Price / Book8.00

Profitability

Trailing EPS$0.77
Net Income$21 million
Net Margins2.65%
Return on Equity6.78%
Return on Assets3.83%

Miscellaneous

Employees5,305
Outstanding Shares40,020,000

athenahealth (NASDAQ:ATHN) Frequently Asked Questions

What is athenahealth's stock symbol?

athenahealth trades on the NASDAQ under the ticker symbol "ATHN."

How were athenahealth's earnings last quarter?

athenahealth, Inc (NASDAQ:ATHN) announced its quarterly earnings data on Thursday, October, 19th. The health services provider reported $0.56 EPS for the quarter, beating the Zacks' consensus estimate of $0.50 by $0.06. The health services provider earned $304.60 million during the quarter, compared to analysts' expectations of $310.52 million. athenahealth had a return on equity of 6.78% and a net margin of 2.65%. The company's revenue for the quarter was up 10.1% compared to the same quarter last year. During the same quarter last year, the firm posted $0.60 earnings per share. View athenahealth's Earnings History.

When will athenahealth make its next earnings announcement?

athenahealth is scheduled to release their next quarterly earnings announcement on Thursday, February, 1st 2018. View Earnings Estimates for athenahealth.

Where is athenahealth's stock going? Where will athenahealth's stock price be in 2018?

24 equities research analysts have issued 1 year target prices for athenahealth's stock. Their predictions range from $88.00 to $186.00. On average, they anticipate athenahealth's share price to reach $141.50 in the next twelve months. View Analyst Ratings for athenahealth.

What are Wall Street analysts saying about athenahealth stock?

Here are some recent quotes from research analysts about athenahealth stock:

  • 1. Cantor Fitzgerald analysts commented, "This morning, athenaHealth filed an 8-K indicating that it implemented a change in control severance plan for certain executives." (10/27/2017)
  • 2. Canaccord Genuity analysts commented, "Date and time of first dissemination: October 27, 2017, 13:00 ET Date and time of production: October 27, 2017, 13:00 ET Target Price / Valuation Methodology: athenahealth – ATHN Our price target of of $123 is based on 3.8x 2018E sales. Risks to achieving Target Price / Valuation: athenahealth – ATHN Physician market consolidation could create headwinds if hospital acquisitions of physician groups shrink the physician office market. Our long-term thesis on athenahealth assumes the company is able to grow in the hospital market. If the company is unable to succeed in this market, our long-term thesis could be at risk. Any changes to reimbursement rates or regulatory changes could pose a risk to athenahealth’s customer base and their ability to collect payments; any such changes could negatively impact athenahealth’s revenue and profitability. Distribution of Ratings: Global Stock Ratings (as of 10/27/17) Rating Coverage Universe IB Clients # % % Buy 567 60.90% 39.68% Hold 252 27.07% 23.41% Sell 23 2.47% 17.39% Speculative Buy 89 9.56% 68.54% 931* 100.0% *Total includes stocks that are Under Review Canaccord Genuity Ratings System BUY: The stock is expected to generate risk-adjusted returns of over 10% during the next 12 months. HOLD: The stock is expected to generate risk-adjusted returns of 0-10% during the next 12 months. SELL: The stock is expected to generate negative risk-adjusted returns during the next 12 months. NOT RATED: Canaccord Genuity does not provide research coverage of the relevant issuer." (10/23/2017)
  • 3. Piper Jaffray Companies analysts commented, "We have updated our model and estimates to reflect the new company presentation. We have slightly lowered our PT to $160 from $162 to reflect our revised estimates. Despite this we remain confident in the company's FY17 outlook, and would be buying shares at current market valuation. Reiterate OW, PT $160." (2/7/2017)
  • 4. Stifel Nicolaus analysts commented, "ATHN reported 4Q EPS after the close 2/2/17 with a call at 8am ET this morning. Revenue ($288.2mn) was 5% ($17mn) below consensus and guidance, while EPS of $0.62 exceeded consensus ($0.51). Management reiterated 2017 revenue, bookings and adjusted operating income guidance; however, with the revenue miss revenue growth must reaccelerate more than previously expected and margins must improve less." (2/6/2017)

Who are some of athenahealth's key competitors?

Who are athenahealth's key executives?

athenahealth's management team includes the folowing people:

  • Jonathan S. Bush, Chairman of the Board, President, Chief Executive Officer (Age 48)
  • Marc Levine, Chief Financial Officer, Executive Vice President, Treasurer (Age 57)
  • Prakash Khot, Senior Vice President, Chief Technology Officer (Age 47)
  • Timothy O'Brien, Senior Vice President, Chief Marketing Officer (Age 41)
  • Dan Haley, Senior Vice President, General Counsel, Secretary (Age 44)
  • Kyle Armbrester, Senior Vice President, Chief Product Officer (Age 32)
  • Brandon H. Hull, Lead Independent Director (Age 56)
  • John A. Kane, Director (Age 64)
  • Brian P. McKeon, Director (Age 54)
  • Thomas J. Szkutak, Director (Age 56)

Who owns athenahealth stock?

athenahealth's stock is owned by a number of of institutional and retail investors. Top institutional investors include Barton Investment Management (0.58%), Schwab Charles Investment Management Inc. (0.50%), Bank of Montreal Can (0.02%), Fox Run Management L.L.C. (0.01%), Daiwa SB Investments Ltd. (0.01%) and State of Alaska Department of Revenue (0.01%). Company insiders that own athenahealth stock include Amy Abernethy, Bradford Kyle Armbrester, Brandon H Hull, Daniel P Haley, David Eric Robinson, Ed Park, John A Kane, Jonathan Bush, Jonathan D Porter, Karl Stubelis, Kristi Ann Matus and Timothy John O'brien. View Institutional Ownership Trends for athenahealth.

Who sold athenahealth stock? Who is selling athenahealth stock?

athenahealth's stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can and Barton Investment Management. Company insiders that have sold athenahealth company stock in the last year include Amy Abernethy, Bradford Kyle Armbrester, Brandon H Hull, Daniel P Haley, David Eric Robinson, John A Kane, Jonathan Bush, Jonathan D Porter and Karl Stubelis. View Insider Buying and Selling for athenahealth.

Who bought athenahealth stock? Who is buying athenahealth stock?

athenahealth's stock was purchased by a variety of institutional investors in the last quarter, including Schwab Charles Investment Management Inc., State of Alaska Department of Revenue, Daiwa SB Investments Ltd. and Fox Run Management L.L.C.. View Insider Buying and Selling for athenahealth.

How do I buy athenahealth stock?

Shares of athenahealth can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is athenahealth's stock price today?

One share of athenahealth stock can currently be purchased for approximately $128.33.

How big of a company is athenahealth?

athenahealth has a market capitalization of $5.14 billion and generates $1.08 billion in revenue each year. The health services provider earns $21 million in net income (profit) each year or $0.77 on an earnings per share basis. athenahealth employs 5,305 workers across the globe.

How can I contact athenahealth?

athenahealth's mailing address is 311 ARSENAL STREET, WATERTOWN MA, 02472. The health services provider can be reached via phone at 617-402-1000 or via email at [email protected]


MarketBeat Community Rating for athenahealth (ATHN)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  506 (Vote Outperform)
Underperform Votes:  561 (Vote Underperform)
Total Votes:  1,067
MarketBeat's community ratings are surveys of what our community members think about athenahealth and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

athenahealth (NASDAQ:ATHN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.252.362.382.43
Ratings Breakdown: 1 Sell Rating(s)
16 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
14 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
13 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
9 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $141.50$141.91$143.55$146.70
Price Target Upside: 12.72% upside4.69% upside13.26% upside5.25% downside

athenahealth (NASDAQ:ATHN) Consensus Price Target History

Price Target History for athenahealth (NASDAQ:ATHN)

athenahealth (NASDAQ:ATHN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/18/2018Evercore ISIInitiated CoverageIn -> In-Line$140.00MediumView Rating Details
1/12/2018KeyCorpReiterated RatingBuy$152.00HighView Rating Details
1/4/2018CitigroupInitiated CoverageNeutralLowView Rating Details
12/8/2017Deutsche BankInitiated CoverageHold -> Hold$145.00HighView Rating Details
10/27/2017Cantor FitzgeraldReiterated RatingHold$120.00N/AView Rating Details
10/25/2017SunTrust BanksReiterated RatingBuy$156.00N/AView Rating Details
10/23/2017Leerink SwannLower Price TargetMarket Perform$155.00 -> $125.00N/AView Rating Details
10/23/2017Wells Fargo & CoLower Price TargetOutperform$190.00 -> $155.00N/AView Rating Details
10/23/2017Canaccord GenuityReiterated RatingHold$144.00 -> $123.00N/AView Rating Details
10/23/2017First AnalysisUpgradeUnderweight -> Equal Weight$125.00 -> $127.00N/AView Rating Details
10/22/2017Robert W. BairdLower Price TargetOutperform$170.00 -> $155.00N/AView Rating Details
10/20/2017Royal Bank of CanadaSet Price TargetHold$144.00N/AView Rating Details
10/20/2017OppenheimerReiterated RatingBuy$184.00N/AView Rating Details
10/17/2017Piper Jaffray CompaniesReiterated RatingBuy$167.00N/AView Rating Details
10/13/2017Jefferies GroupSet Price TargetHold$120.00 -> $110.00N/AView Rating Details
8/2/2017Morgan StanleyReiterated RatingEqual Weight$108.00 -> $125.00LowView Rating Details
7/31/2017CowenDowngradeOutperform -> Market Perform$127.00 -> $133.00MediumView Rating Details
7/21/2017William BlairReiterated RatingMarket PerformMediumView Rating Details
7/19/2017JPMorgan Chase & Co.Set Price TargetHold$136.00LowView Rating Details
7/7/2017Dougherty & CoDowngradeBuy -> NeutralHighView Rating Details
7/7/2017ArgusInitiated CoverageHoldHighView Rating Details
6/16/2017Stifel NicolausReiterated RatingHold$106.00 -> $151.00LowView Rating Details
5/1/2017BarclaysSet Price TargetUnderweight$97.00 -> $88.00MediumView Rating Details
2/7/2017Berenberg BankInitiated CoverageBuy$143.00N/AView Rating Details
1/4/2017Pacific CrestUpgradeOverweight$140.00N/AView Rating Details
7/22/2016FBR & CoLower Price TargetMarket Perform$145.00 -> $140.00N/AView Rating Details
2/8/2016Goldman Sachs GroupLower Price TargetNeutral$155.00 -> $149.00N/AView Rating Details
2/8/2016Topeka Capital MarketsUpgradeHold -> Buy$169.00 -> $160.00N/AView Rating Details
(Data available from 1/22/2016 forward)

Earnings

athenahealth (NASDAQ:ATHN) Earnings History and Estimates Chart

Earnings by Quarter for athenahealth (NASDAQ:ATHN)

athenahealth (NASDAQ ATHN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/5/2018$0.63N/AView Earnings Details
10/19/2017Q3 2017$0.50$0.56$310.52 million$304.60 millionViewN/AView Earnings Details
7/20/2017Q2 2017$0.39$0.51$298.68 million$301.10 millionViewN/AView Earnings Details
4/27/2017Q1 2017$0.11$0.10$296.49 million$285.40 millionViewN/AView Earnings Details
2/2/2017Q4 2016$0.51$0.62$303.72 million$288.20 millionViewListenView Earnings Details
10/20/2016Q3$0.47$0.60$280.17 million$276.67 millionViewListenView Earnings Details
7/21/2016Q2$0.42$0.34$274.07 million$261.90 millionViewListenView Earnings Details
4/28/2016Q1$0.26$0.34$248.49 million$256.15 millionViewListenView Earnings Details
2/4/2016Q415$0.41$0.45$257.68 million$257.50 millionViewN/AView Earnings Details
10/22/2015Q315$0.26$0.36$233.03 million$236.10 millionViewListenView Earnings Details
7/23/2015Q215$0.25$0.32$227.08 million$224.70 millionViewListenView Earnings Details
4/30/2015Q115($0.10)$0.24$205.24 million$206.40 millionViewListenView Earnings Details
2/5/2015Q414$0.39$0.58$207.99 million$213.20 millionViewN/AView Earnings Details
10/16/2014Q314$0.27$0.27$190.40 million$190.40 millionViewListenView Earnings Details
7/17/2014Q214$0.22$0.32$182.14 million$185.90 millionViewN/AView Earnings Details
4/17/2014Q114($0.01)$0.12$170.03 million$163.00 millionViewListenView Earnings Details
2/6/2014Q413$0.45$0.57$168.39 million$171.60 millionViewN/AView Earnings Details
10/17/2013Q313$0.31$0.29$154.80 million$151.50 millionViewN/AView Earnings Details
7/18/2013Q2 2013$0.22($0.08)$148.24 million$149.30 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.23$0.38$121.05 million$125.60 millionViewListenView Earnings Details
2/7/2013Q4 2012$0.28$0.29$116.97 million$116.30 millionViewListenView Earnings Details
10/18/2012$0.26$0.30ViewN/AView Earnings Details
7/19/2012$0.23$0.24ViewN/AView Earnings Details
4/26/2012$0.17$0.17ViewN/AView Earnings Details
2/15/2012$0.23$0.26ViewN/AView Earnings Details
10/20/2011$0.20$0.24ViewN/AView Earnings Details
7/21/2011$0.19$0.22ViewN/AView Earnings Details
4/28/2011$0.13$0.17ViewN/AView Earnings Details
2/17/2011$0.20$0.28ViewN/AView Earnings Details
10/21/2010Q3 2010$0.08$0.11ViewN/AView Earnings Details
7/22/2010Q2 2010$0.06$0.04ViewN/AView Earnings Details
4/29/2010Q1 2010$0.10$0.02ViewN/AView Earnings Details
3/15/2010Q4 2009$0.12$0.12ViewN/AView Earnings Details
10/29/2009Q3 2009$0.10$0.08ViewN/AView Earnings Details
8/5/2009Q2 2009$0.09$0.09ViewN/AView Earnings Details
4/30/2009Q1 2009$0.10$0.07ViewN/AView Earnings Details
2/26/2009Q4 2008$0.13$0.11ViewN/AView Earnings Details
11/6/2008Q3 2008$0.09$0.11ViewN/AView Earnings Details
8/4/2008Q2 2008$0.07$0.08ViewN/AView Earnings Details
5/6/2008Q1 2008$0.06$0.05ViewN/AView Earnings Details
3/5/2008Q4 2007$0.06$0.06ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

athenahealth (NASDAQ:ATHN) Earnings Estimates

2018 EPS Consensus Estimate: $1.41
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.22$0.22$0.22
Q2 20181$0.33$0.33$0.33
Q3 20181$0.34$0.34$0.34
Q4 20181$0.52$0.52$0.52
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for athenahealth (NASDAQ:ATHN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

athenahealth (NASDAQ ATHN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.20%
Insider Trades by Quarter for athenahealth (NASDAQ:ATHN)
Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

athenahealth (NASDAQ ATHN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/29/2018Jonathan D. PorterSVPSell150$134.52$20,178.00View SEC Filing  
12/26/2018Amy AbernethyDirectorSell500$134.18$67,090.004,045View SEC Filing  
12/26/2018Jonathan BushCEOSell30,000$134.80$4,044,000.00320,807View SEC Filing  
1/2/2018David Eric RobinsonDirectorSell5,000$133.94$669,700.008,596View SEC Filing  
12/29/2017Jonathan D PorterSVPSell150$134.52$20,178.00View SEC Filing  
12/26/2017Amy AbernethyDirectorSell500$134.18$67,090.004,045View SEC Filing  
12/26/2017Jonathan BushCEOSell30,000$134.80$4,044,000.00320,807View SEC Filing  
12/1/2017Brandon H. HullDirectorSell800$132.97$106,376.00View SEC Filing  
11/20/2017Brandon H. HullDirectorSell800$130.00$104,000.00View SEC Filing  
10/27/2017Bradford Kyle ArmbresterSVPSell1,000$128.56$128,560.00View SEC Filing  
10/20/2017Brandon H. HullDirectorSell800$130.00$104,000.00View SEC Filing  
10/2/2017Daniel P HaleyInsiderSell1,583$124.56$197,178.4813,408View SEC Filing  
10/2/2017Jonathan BushCEOSell4,000$124.17$496,680.00319,807View SEC Filing  
9/15/2017Jonathan D. PorterSVPSell300$130.38$39,114.00View SEC Filing  
9/1/2017Brandon H. HullDirectorSell800$140.95$112,760.00View SEC Filing  
9/1/2017Jonathan BushCEOSell4,000$139.77$559,080.00319,807View SEC Filing  
8/15/2017Jonathan D. PorterSVPSell300$142.88$42,864.00View SEC Filing  
8/1/2017Brandon H. HullDirectorSell800$140.01$112,008.00View SEC Filing  
8/1/2017Jonathan BushCEOSell4,000$143.31$573,240.00319,807View SEC Filing  
7/21/2017Jonathan D. PorterSVPSell422$154.00$64,988.00View SEC Filing  
7/17/2017Jonathan D. PorterSVPSell300$143.13$42,939.00View SEC Filing  
7/3/2017Brandon H. HullDirectorSell800$140.81$112,648.00View SEC Filing  
7/3/2017Jonathan BushCEOSell4,000$140.52$562,080.00319,807View SEC Filing  
6/15/2017Jonathan D. PorterSVPSell300$142.27$42,681.00View SEC Filing  
6/5/2017Karl StubelisCFOSell3,952$138.98$549,248.9621,810View SEC Filing  
5/18/2017Bradford Kyle ArmbresterSVPSell2,431$130.00$316,030.00View SEC Filing  
5/18/2017Brandon H. HullDirectorSell1,600$130.00$208,000.00View SEC Filing  
5/18/2017Jonathan BushCEOSell4,000$125.85$503,400.00319,807View SEC Filing  
5/15/2017Jonathan D. PorterSVPSell300$109.48$32,844.00View SEC Filing  
4/25/2017Jonathan BushCEOSell8,000$120.00$960,000.00319,807View SEC Filing  
1/27/2017John A KaneDirectorSell2,875$123.11$353,941.258,958View SEC Filing  
1/12/2017Jonathan BushCEOSell4,000$120.00$480,000.00312,109View SEC Filing  
12/15/2016Amy AbernethyDirectorSell1,000$117.15$117,150.002,649View SEC Filing  
12/15/2016Ed ParkCOOSell2,500$117.15$292,875.0013,219View SEC Filing  
12/15/2016Jonathan BushCEOSell8,000$120.00$960,000.00312,109View SEC Filing  
12/1/2016Ed ParkCOOSell1,500$94.60$141,900.0010,719View SEC Filing  
10/27/2016John A. KaneDirectorSell5,750$122.63$705,122.50View SEC Filing  
10/10/2016Bradford Kyle ArmbresterSVPSell2,545$130.00$330,850.00View SEC Filing  
10/10/2016Brandon H HullDirectorSell2,400$130.00$312,000.003,987View SEC Filing  
10/3/2016Daniel P HaleySVPSell2,109$124.43$262,422.873,195View SEC Filing  
10/3/2016Jonathan BushCEOSell4,000$124.34$497,360.00312,109View SEC Filing  
9/7/2016Karl StubelisVPSell928$123.36$114,478.081,375View SEC Filing  
8/15/2016Ed ParkCOOSell4,000$124.20$496,800.0020,719View SEC Filing  
8/1/2016Jonathan BushCEOSell4,000$128.19$512,760.00312,109View SEC Filing  
7/27/2016John A KaneDirectorSell2,875$128.81$370,328.7510,708View SEC Filing  
7/6/2016Ed ParkCOOSell1,500$136.85$205,275.0018,819View SEC Filing  
7/1/2016Brandon H HullDirectorSell800$137.48$109,984.006,387View SEC Filing  
7/1/2016Jonathan BushCEOSell4,000$138.21$552,840.00312,109View SEC Filing  
6/2/2016Brandon H HullDirectorSell800$130.00$104,000.007,187View SEC Filing  
6/1/2016Ed ParkCOOSell1,500$125.82$188,730.0019,819View SEC Filing  
6/1/2016Jonathan BushCEOSell4,000$125.97$503,880.00312,109View SEC Filing  
5/4/2016Ed ParkCOOSell1,500$127.81$191,715.0021,819View SEC Filing  
5/2/2016Brandon H HullDirectorSell800$132.74$106,192.007,987View SEC Filing  
5/2/2016Jonathan BushCEOSell4,000$132.09$528,360.00312,109View SEC Filing  
5/2/2016Kristi Ann MatusEVPSell415$133.27$55,307.0534,116View SEC Filing  
4/25/2016Karl StubelisVPSell547$138.64$75,836.08View SEC Filing  
4/6/2016Ed ParkCOOSell1,500$139.15$208,725.0022,919View SEC Filing  
4/1/2016Brandon H HullDirectorSell800$137.72$110,176.008,787View SEC Filing  
4/1/2016Jonathan BushCEOSell4,000$138.44$553,760.00307,408View SEC Filing  
4/1/2016Kristi Ann MatusEVPSell415$138.61$57,523.1534,531View SEC Filing  
3/3/2016Bradford Kyle ArmbresterSVPSell1,369$132.04$180,762.76View SEC Filing  
3/1/2016Brandon H HullDirectorSell1,600$130.00$208,000.008,687View SEC Filing  
3/1/2016Daniel P HaleySVPSell1,279$130.64$167,088.56365View SEC Filing  
3/1/2016Ed ParkCOOSell1,500$131.66$197,490.0026,270View SEC Filing  
3/1/2016Jonathan BushCEOSell4,000$129.61$518,440.00312,109View SEC Filing  
3/1/2016Kristi Ann MatusEVPSell415$129.53$53,754.9533,357View SEC Filing  
3/1/2016Timothy John O'brienCMOSell846$132.25$111,883.5062View SEC Filing  
2/16/2016Bradford Kyle ArmbresterSVPSell1,657$127.11$210,621.272,500View SEC Filing  
2/16/2016Timothy John O'brienCMOSell816$127.08$103,697.281,250View SEC Filing  
2/3/2016Ed ParkCOOSell1,500$140.61$210,915.0027,433View SEC Filing  
2/1/2016Jonathan BushCEOSell4,000$140.14$560,560.00308,109View SEC Filing  
2/1/2016Kristi Ann MatusEVPSell415$141.08$58,548.2033,772View SEC Filing  
1/27/2016John A. KaneDirectorSell2,875$140.81$404,828.756,133View SEC Filing  
1/6/2016Ed ParkCOOSell1,500$161.89$242,835.0028,933View SEC Filing  
1/4/2016Jonathan BushCEOSell4,000$156.79$627,160.00308,109View SEC Filing  
1/4/2016Kristi Ann MatusEVPSell415$159.06$66,009.9034,187View SEC Filing  
12/2/2015Ed ParkCOOSell1,500$166.81$250,215.0030,433View SEC Filing  
11/20/2015Stephen N KahaneEVPSell1,280$157.80$201,984.0017,829View SEC Filing  
11/6/2015Stephen N KahaneEVPSell5,000$159.51$797,550.0019,109View SEC Filing  
11/4/2015Ed ParkCOOSell1,500$162.32$243,480.0031,933View SEC Filing  
11/3/2015Jonathan BushCEOSell14,750$156.50$2,308,375.00311,234View SEC Filing  
10/27/2015John A. KaneDirectorSell2,875$150.44$432,515.006,133View SEC Filing  
10/23/2015Jonathan BushCEOSell20,000$157.50$3,150,000.00311,234View SEC Filing  
10/23/2015Robert CosinukeCMOSell1,211$159.02$192,573.2240,322View SEC Filing  
10/23/2015Stephen N KahaneEVPSell5,000$150.50$752,500.0024,109View SEC Filing  
10/20/2015Stephen N KahaneEVPSell2,000$132.88$265,760.0029,109View SEC Filing  
10/7/2015Ed ParkCOOSell1,500$134.23$201,345.0033,433View SEC Filing  
10/2/2015Jonathan BushCEOSell1,000$130.74$130,740.00311,234View SEC Filing  
9/15/2015Stephen N KahaneEVPSell2,000$135.77$271,540.0031,031View SEC Filing  
9/2/2015Ed ParkCOOSell1,500$129.64$194,460.0034,933View SEC Filing  
9/2/2015Jonathan BushCEOSell1,000$131.09$131,090.00311,234View SEC Filing  
8/18/2015Stephen N KahaneEVPSell2,000$141.49$282,980.00View SEC Filing  
7/24/2015David Eric RobinsonDirectorSell10,000$130.00$1,300,000.00View SEC Filing  
7/21/2015Stephen N KahaneEVPSell2,000$117.32$234,640.00View SEC Filing  
7/2/2015Jonathan BushCEOSell1,000$114.17$114,170.00View SEC Filing  
6/2/2015Jonathan BushCEOSell1,000$115.32$115,320.00View SEC Filing  
4/27/2015John A KaneDirectorSell2,875$125.35$360,381.25View SEC Filing  
4/14/2015Karl StubelisVPSell1,115$126.28$140,802.20View SEC Filing  
4/2/2015Jonathan BushCEOSell1,000$118.77$118,770.00View SEC Filing  
3/10/2015James L MannDirectorSell13,106$121.27$1,589,364.62View SEC Filing  
3/3/2015Robert CosinukeCMOSell6,000$128.15$768,900.00View SEC Filing  
2/24/2015Jonathan BushCEOSell2,499$130.23$325,444.77View SEC Filing  
2/18/2015Jonathan BushCEOSell2,498$132.04$329,835.92View SEC Filing  
2/10/2015Jonathan BushCEOSell7,495$135.82$1,017,970.90View SEC Filing  
2/5/2015David Eric RobinsonDirectorSell25,000$143.17$3,579,250.00View SEC Filing  
2/3/2015Robert CosinukeCMOSell6,000$139.06$834,360.00View SEC Filing  
1/5/2015David Eric RobinsonDirectorSell25,000$145.14$3,628,500.00View SEC Filing  
1/5/2015Robert CosinukeCMOSell6,000$145.18$871,080.00View SEC Filing  
12/22/2014Robert CosinukeCMOSell6,000$139.32$835,920.00View SEC Filing  
12/2/2014Jonathan BushCEOSell1,000$116.55$116,550.00View SEC Filing  
10/10/2014Robert CosinukeCMOSell3,000$123.78$371,340.00View SEC Filing  
10/2/2014Jonathan BushCEOSell1,000$128.41$128,410.00View SEC Filing  
9/10/2014Robert CosinukeCMOSell6,000$138.08$828,480.00View SEC Filing  
8/11/2014Robert CosinukeCMOSell6,000$129.43$776,580.00View SEC Filing  
8/4/2014Jonathan BushCEOSell1,000$121.58$121,580.00View SEC Filing  
7/10/2014Robert CosinukeCMOSell6,000$120.10$720,600.00View SEC Filing  
7/2/2014Jonathan BushCEOSell1,000$129.45$129,450.00View SEC Filing  
7/1/2014Stephen N KahaneInsiderSell5,000$127.60$638,000.00View SEC Filing  
6/12/2014David Eric RobinsonDirectorSell30,000$124.12$3,723,600.00View SEC Filing  
6/10/2014Robert CosinukeCMOSell6,000$125.07$750,420.00View SEC Filing  
6/2/2014Jonathan BushCEOSell1,000$125.82$125,820.00View SEC Filing  
6/2/2014Stephen N KahaneInsiderSell5,000$126.42$632,100.00View SEC Filing  
5/2/2014Jonathan BushCEOSell1,000$123.21$123,210.00311,234View SEC Filing  
5/1/2014Stephen KahaneInsiderSell5,000$121.96$609,800.0064,285View SEC Filing  
4/16/2014Stephen KahaneInsiderSell10,000$143.96$1,439,600.0069,285View SEC Filing  
4/14/2014David Eric RobinsonDirectorSell60,000$140.61$8,436,600.003,692View SEC Filing  
4/10/2014Robert CosinukeCMOSell6,000$151.14$906,840.0044,804View SEC Filing  
4/2/2014Jonathan BushCEOSell1,000$161.74$161,740.00311,234View SEC Filing  
3/10/2014Robert CosinukeCMOSell6,000$181.60$1,089,600.0046,277View SEC Filing  
2/18/2014Timothy AdamsCFOSell30,000$194.58$5,837,400.0040,327View SEC Filing  
2/12/2014Dev IttycheriaDirectorSell2,000$181.17$362,340.008,574View SEC Filing  
2/10/2014Robert CosinukeCMOSell6,000$172.72$1,036,320.0053,321View SEC Filing  
2/3/2014Daniel OrensteinSVPSell1,000$146.73$146,730.0031,262View SEC Filing  
2/3/2014David Eric RobinsonDirectorSell4,000$146.86$587,440.002,058View SEC Filing  
1/10/2014Robert CosinukeCMOSell6,000$132.92$797,520.0053,321View SEC Filing  
1/3/2014David Eric RobinsonDirectorSell4,000$131.86$527,440.002,058View SEC Filing  
12/10/2013Robert CosinukeCMOSell6,000$132.77$796,620.0053,321View SEC Filing  
12/3/2013David Eric RobinsonDirectorSell4,000$132.48$529,920.002,058View SEC Filing  
12/2/2013Jonathan BushCEOSell1,000$132.24$132,240.00311,759View SEC Filing  
11/4/2013David Eric RobinsonDirectorSell4,000$137.26$549,040.00View SEC Filing  
11/4/2013Jonathan BushCEOSell1,000$137.26$137,260.00View SEC Filing  
11/1/2013Daniel H OrensteinSVPSell1,000$133.15$133,150.00View SEC Filing  
10/21/2013Timothy M AdamsCFOSell20,000$138.39$2,767,800.00View SEC Filing  
10/18/2013Ed ParkCOOSell10,021$123.36$1,236,190.56View SEC Filing  
10/18/2013Jonathan BushCEOSell20,000$120.00$2,400,000.00View SEC Filing  
10/10/2013Robert CosinukeCMOSell6,000$108.21$649,260.0053,321View SEC Filing  
10/3/2013David Eric RobinsonDirectorSell4,000$111.01$444,040.00View SEC Filing  
10/2/2013Jonathan BushCEOSell1,000$110.16$110,160.00View SEC Filing  
9/10/2013Robert CosinukeCMOSell6,000$109.68$658,080.00View SEC Filing  
9/3/2013Daniel OrensteinSVPSell1,000$106.73$106,730.0031,262View SEC Filing  
9/3/2013David Eric RobinsonDirectorSell4,000$106.53$426,120.002,058View SEC Filing  
9/3/2013Jonathan BushCEOSell22,105$106.45$2,353,077.25302,231View SEC Filing  
8/19/2013John KaneDirectorSell2,000$111.23$222,460.005,052View SEC Filing  
8/15/2013John KaneDirectorSell5,000$110.03$550,150.005,052View SEC Filing  
8/12/2013Robert CosinukeCMOSell6,000$115.72$694,320.0053,321View SEC Filing  
8/5/2013David Eric RobinsonDirectorSell4,000$114.01$456,040.00View SEC Filing  
8/1/2013Daniel H OrensteinSVPSell1,000$113.73$113,730.00View SEC Filing  
8/1/2013Jonathan BushCEOSell5,000$113.94$569,700.00302,231View SEC Filing  
7/12/2013Timothy M AdamsCFOSell10,000$106.14$1,061,400.00View SEC Filing  
7/11/2013David Eric RobinsonDirectorSell4,000$90.00$360,000.00View SEC Filing  
7/10/2013Robert CosinukeCMOSell6,000$87.06$522,360.00View SEC Filing  
7/1/2013Daniel H OrensteinSVPSell1,000$85.01$85,010.00View SEC Filing  
7/1/2013Jonathan BushCEOSell5,000$85.39$426,950.00View SEC Filing  
6/17/2013David Eric RobinsonDirectorSell4,000$90.00$360,000.00View SEC Filing  
6/10/2013Robert CosinukeCMOSell6,000$85.74$514,440.00View SEC Filing  
6/3/2013Daniel H OrensteinSVPSell1,000$84.22$84,220.00View SEC Filing  
6/3/2013Jonathan BushCEOSell5,000$84.39$421,950.00View SEC Filing  
5/10/2013Robert CosinukeCMOSell6,000$84.80$508,800.00View SEC Filing  
5/1/2013Jonathan BushCEOSell5,000$95.70$478,500.00View SEC Filing  
2/26/2013David Eric RobinsonDirectorSell10,000$90.13$901,300.00View SEC Filing  
8/10/2012Robert CosinukeCMOSell3,000$92.35$277,050.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

athenahealth (NASDAQ ATHN) News Headlines

Source:
DateHeadline
Head-To-Head Analysis: athenahealth (ATHN) and Cotiviti (COTV)Head-To-Head Analysis: athenahealth (ATHN) and Cotiviti (COTV)
www.americanbankingnews.com - January 20 at 3:16 AM
Oversold Conditions For Athenahealth (ATHN)Oversold Conditions For Athenahealth (ATHN)
www.nasdaq.com - January 19 at 9:33 AM
athenahealth (ATHN) Research Coverage Started at Evercore ISIathenahealth (ATHN) Research Coverage Started at Evercore ISI
www.americanbankingnews.com - January 18 at 4:46 PM
Zacks: Analysts Expect athenahealth, Inc (ATHN) Will Announce Quarterly Sales of $322.14 MillionZacks: Analysts Expect athenahealth, Inc (ATHN) Will Announce Quarterly Sales of $322.14 Million
www.americanbankingnews.com - January 18 at 10:38 AM
athenahealth, Inc (ATHN) Given Average Recommendation of "Hold" by Brokeragesathenahealth, Inc (ATHN) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - January 16 at 12:40 PM
 Analysts Expect athenahealth, Inc (ATHN) to Announce $0.64 EPS Analysts Expect athenahealth, Inc (ATHN) to Announce $0.64 EPS
www.americanbankingnews.com - January 16 at 11:42 AM
KeyCorp Reaffirms Buy Rating for athenahealth (ATHN)KeyCorp Reaffirms Buy Rating for athenahealth (ATHN)
www.americanbankingnews.com - January 13 at 9:36 PM
Athenahealth files expansion plans at Atlantas Ponce City MarketAthenahealth files expansion plans at Atlanta's Ponce City Market
www.bizjournals.com - January 13 at 3:22 PM
Analyst: When Americans Sneeze, Teladoc And Athenahealth Profit - BenzingaAnalyst: When Americans Sneeze, Teladoc And Athenahealth Profit - Benzinga
www.benzinga.com - January 9 at 8:43 AM
Analyst: When Americans Sneeze, Teladoc And Athenahealth ProfitAnalyst: When Americans Sneeze, Teladoc And Athenahealth Profit
finance.yahoo.com - January 9 at 8:43 AM
athenahealth Announces Fourth Quarter and Full Year 2017 Earnings Conference Call - GlobeNewswire (press release)athenahealth Announces Fourth Quarter and Full Year 2017 Earnings Conference Call - GlobeNewswire (press release)
globenewswire.com - January 8 at 11:09 AM
athenahealth Announces Fourth Quarter and Full Year 2017 Earnings Conference Callathenahealth Announces Fourth Quarter and Full Year 2017 Earnings Conference Call
finance.yahoo.com - January 8 at 11:09 AM
Whats Happening With These Healthcare Information Services Stocks? -- Evolent Health, athenahealth, HealthEquity ... - PR Newswire (press release)What's Happening With These Healthcare Information Services Stocks? -- Evolent Health, athenahealth, HealthEquity ... - PR Newswire (press release)
www.prnewswire.com - January 5 at 3:26 PM
David Eric Robinson Sells 5,000 Shares of athenahealth, Inc (ATHN) StockDavid Eric Robinson Sells 5,000 Shares of athenahealth, Inc (ATHN) Stock
www.americanbankingnews.com - January 4 at 7:32 PM
Research Report Identifies A10 Networks, athenahealth, Voyager Therapeutics, Sunshine, Hannon Armstrong Sustainable Infrastructure Capital, and WMIH with Renewed Outlook — Fundamental Analysis, Calculating Forward MovementResearch Report Identifies A10 Networks, athenahealth, Voyager Therapeutics, Sunshine, Hannon Armstrong Sustainable Infrastructure Capital, and WMIH with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
finance.yahoo.com - January 4 at 8:02 AM
athenahealth (ATHN) Coverage Initiated by Analysts at Citigroupathenahealth (ATHN) Coverage Initiated by Analysts at Citigroup
www.americanbankingnews.com - January 4 at 7:44 AM
Jonathan D. Porter Sells 150 Shares of athenahealth, Inc (ATHN) StockJonathan D. Porter Sells 150 Shares of athenahealth, Inc (ATHN) Stock
www.americanbankingnews.com - January 3 at 12:58 AM
Insider Selling: athenahealth, Inc (ATHN) SVP Sells 150 Shares of StockInsider Selling: athenahealth, Inc (ATHN) SVP Sells 150 Shares of Stock
www.americanbankingnews.com - January 2 at 7:58 PM
 Analysts Anticipate athenahealth, Inc (ATHN) Will Announce Quarterly Sales of $323.07 Million Analysts Anticipate athenahealth, Inc (ATHN) Will Announce Quarterly Sales of $323.07 Million
www.americanbankingnews.com - January 1 at 8:52 AM
athenahealth, Inc (ATHN) Director Sells $67,090.00 in Stockathenahealth, Inc (ATHN) Director Sells $67,090.00 in Stock
www.americanbankingnews.com - January 1 at 5:26 AM
Jonathan Bush Sells 30,000 Shares of athenahealth, Inc (ATHN) StockJonathan Bush Sells 30,000 Shares of athenahealth, Inc (ATHN) Stock
www.americanbankingnews.com - January 1 at 4:26 AM
Zacks: Analysts Anticipate athenahealth, Inc (ATHN) to Post $0.64 EPSZacks: Analysts Anticipate athenahealth, Inc (ATHN) to Post $0.64 EPS
www.americanbankingnews.com - December 30 at 3:14 PM
athenahealth, Inc (ATHN) CEO Jonathan Bush Sells 30,000 Sharesathenahealth, Inc (ATHN) CEO Jonathan Bush Sells 30,000 Shares
www.americanbankingnews.com - December 29 at 9:26 AM
Amy Abernethy Sells 500 Shares of athenahealth, Inc (ATHN) StockAmy Abernethy Sells 500 Shares of athenahealth, Inc (ATHN) Stock
www.americanbankingnews.com - December 29 at 12:32 AM
Athenahealth Sees RS Rating Improve To 74Athenahealth Sees RS Rating Improve To 74
finance.yahoo.com - December 27 at 3:14 PM
Abbott (ABT) at a 52-Week High: Whats Driving the Stock?Abbott (ABT) at a 52-Week High: What's Driving the Stock?
www.msn.com - December 22 at 3:45 PM
athenahealth, Inc (ATHN) Given Consensus Recommendation of "Hold" by Brokeragesathenahealth, Inc (ATHN) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - December 22 at 11:58 AM
Why athenahealth (ATHN) Could Be Positioned for a Surge - Nasdaq - NasdaqWhy athenahealth (ATHN) Could Be Positioned for a Surge - Nasdaq - Nasdaq
www.nasdaq.com - December 19 at 7:56 AM
athenahealth to Present at the 36th Annual J.P. Morgan Healthcare Conferenceathenahealth to Present at the 36th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 18 at 3:23 PM
Why athenahealth (ATHN) Could Be Positioned for a SurgeWhy athenahealth (ATHN) Could Be Positioned for a Surge
finance.yahoo.com - December 18 at 3:23 PM
athenahealth (ATHN) Stock Rating Upgraded by BidaskClubathenahealth (ATHN) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - December 16 at 9:56 AM
ETFs with exposure to athenahealth, Inc. : December 15, 2017ETFs with exposure to athenahealth, Inc. : December 15, 2017
finance.yahoo.com - December 15 at 3:25 PM
Zacks: Brokerages Anticipate athenahealth, Inc. (ATHN) Will Post Quarterly Sales of $323.07 MillionZacks: Brokerages Anticipate athenahealth, Inc. (ATHN) Will Post Quarterly Sales of $323.07 Million
www.americanbankingnews.com - December 15 at 6:44 AM
athenahealth, Inc. (ATHN) Expected to Announce Earnings of $0.64 Per Shareathenahealth, Inc. (ATHN) Expected to Announce Earnings of $0.64 Per Share
www.americanbankingnews.com - December 13 at 11:36 AM
athenahealth (ATHN) Receives New Coverage from Analysts at Deutsche Bankathenahealth (ATHN) Receives New Coverage from Analysts at Deutsche Bank
www.americanbankingnews.com - December 8 at 11:12 PM
Stocks Generating Improved Relative Strength: AthenahealthStocks Generating Improved Relative Strength: Athenahealth
finance.yahoo.com - December 8 at 3:23 PM
athenahealth (ATHN) a Buy on Robust Earnings Visibility - Investorplace.comathenahealth (ATHN) a Buy on Robust Earnings Visibility - Investorplace.com
investorplace.com - December 8 at 7:55 AM
athenahealth (ATHN) a Buy on Robust Earnings Visibilityathenahealth (ATHN) a Buy on Robust Earnings Visibility
investorplace.com - December 7 at 1:42 PM
3 Healthcare Stocks to Buy After CVS & Aetna Deal3 Healthcare Stocks to Buy After CVS & Aetna Deal
finance.yahoo.com - December 5 at 7:49 AM
athenahealth, Inc. (ATHN) Director Sells $106,376.00 in Stockathenahealth, Inc. (ATHN) Director Sells $106,376.00 in Stock
www.americanbankingnews.com - December 4 at 9:02 PM
Financial Review: Press Ganey (PGND) & athenahealth (ATHN)Financial Review: Press Ganey (PGND) & athenahealth (ATHN)
www.americanbankingnews.com - December 4 at 9:42 AM
athenahealth (ATHN) Upgraded at BidaskClubathenahealth (ATHN) Upgraded at BidaskClub
www.americanbankingnews.com - December 2 at 3:22 PM
Earnings Visibility Make athenahealth (ATHN) a Buy - Investorplace.comEarnings Visibility Make athenahealth (ATHN) a Buy - Investorplace.com
investorplace.com - December 1 at 10:05 AM
Earnings Visibility Make athenahealth (ATHN) a BuyEarnings Visibility Make athenahealth (ATHN) a Buy
investorplace.com - November 30 at 12:52 PM
Athenahealth (ATHN) Names Marc Levine as CFO and Treasurer - StreetInsider.comAthenahealth (ATHN) Names Marc Levine as CFO and Treasurer - StreetInsider.com
www.streetinsider.com - November 28 at 5:49 AM
Athenahealth appoints third CFO in two yearsAthenahealth appoints third CFO in two years
finance.yahoo.com - November 28 at 5:49 AM
Athenahealth names Marc Levine CFOAthenahealth names Marc Levine CFO
finance.yahoo.com - November 28 at 5:49 AM
athenahealth, Inc. (ATHN) Given Average Rating of "Hold" by Brokeragesathenahealth, Inc. (ATHN) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - November 27 at 10:58 AM
athenahealth, Inc. (ATHN) Given Consensus Rating of "Hold" by Brokeragesathenahealth, Inc. (ATHN) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - November 27 at 10:58 AM
athenahealth, Inc. (ATHN) Given Consensus Recommendation of "Hold" by Brokeragesathenahealth, Inc. (ATHN) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - November 27 at 10:58 AM

SEC Filings

athenahealth (NASDAQ:ATHN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

athenahealth (NASDAQ:ATHN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

athenahealth (NASDAQ ATHN) Stock Chart for Monday, January, 22, 2018

Loading chart…

This page was last updated on 1/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.